Singapore markets closed
Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,139.83 +60.97 (+0.75%) Bitcoin USD
63,577.99 +510.14 (+0.81%) CMC Crypto 200
1,389.45 -7.08 (-0.51%)
Revance Therapeutics, Inc. (RVNC)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 3.2900 |
| Open | 3.3000 |
| Bid | 3.3900 x 500 |
| Ask | 3.4200 x 1000 |
| Day's range | 3.2100 - 3.5600 |
| 52-week range | 3.2100 - 37.9800 |
| Volume | |
| Avg. volume | 1,838,168 |
| Market cap | 354.334M |
| Beta (5Y monthly) | 1.09 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.8300 |
| Earnings date | 06 May 2024 - 21 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 14.91 |
- Business Wire
Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting
NASHVILLE, Tenn., April 12, 2024--Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting
Simply Wall St.Revance Therapeutics, Inc. (NASDAQ:RVNC) is favoured by institutional owners who hold 63% of the company
Key Insights Institutions' substantial holdings in Revance Therapeutics implies that they have significant influence...
- Business Wire
Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NASHVILLE, Tenn., March 27, 2024--Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
© 2024 Yahoo. All rights reserved.